Cargando…
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
The possible causal relationship between interferon-β exposure and pulmonary arterial hypertension development requires close follow-up of patients on treatment with interferon-β http://bit.ly/2OPGSVP
Autores principales: | Anthi, Anastasia, Stagaki, Eleni, Rallidis, Loukianos, Konstantonis, Dimitrios, Evangelopoulos, Maria-Eleftheria, Voumvourakis, Konstantinos, Armaganidis, Apostolos, Orfanos, Stylianos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073410/ https://www.ncbi.nlm.nih.gov/pubmed/32201683 http://dx.doi.org/10.1183/23120541.00328-2019 |
Ejemplares similares
-
The Role of Exercise Doppler Echocardiography to Unmask Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis and Equivocal Baseline Echocardiographic Values for Pulmonary Hypertension
por: Rallidis, Loukianos S., et al.
Publicado: (2021) -
Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension
por: Rallidis, Loukianos S., et al.
Publicado: (2021) -
The wide spectrum of β-thalassaemia intermedia-induced pulmonary hypertension: two case reports on the possible role of specific pulmonary arterial hypertension therapy
por: Anthi, Anastasia, et al.
Publicado: (2021) -
Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Bournia, Vasiliki Kalliopi, et al.
Publicado: (2020) -
A Severe COVID-19 Case Complicated by Right Atrium Thrombus
por: Anthi, Anastasia, et al.
Publicado: (2020)